First, seasonal influenza activity remains low nationally, although there have been small increases in some parts of the country. As of Week 41, the percentage of specimens testing positive for influenza in clinical laboratories remained stable compared to the previous week. The most frequently reported influenza viruses were influenza A(H1N1). 

Outpatient respiratory illness visits accounted for 2.3% of patient visits, which is below the national baseline of 2.9%. The ILI activity remained stable compared to the previous week, and all 10 Health and Human Services (HHS) regions were below their respective baselines.

FluSurv-NET reported a total of 103 laboratory-confirmed influenza-associated hospitalizations between October 1, 2023, and October 14, 2023. The weekly hospitalization rate was 0.2 per 100,000 population, and the overall cumulative hospitalization rate was 0.3 per 100,000 population.

The percentage of deaths attributed to pneumonia and influenza (P&I) remained stable compared to the previous week, below the epidemic threshold. No influenza-associated pediatric deaths have been reported during the 2023-2024 season.

CDC recommends annual influenza vaccination for everyone aged 6 months and older. Antiviral medications are also available for the treatment of influenza.

These surveillance indicators help monitor and track influenza activity, guide public health recommendations, and inform prevention and response strategies.